Background: The genetic background of patients with hemoglobin (Hb) H disease in Taiwan has been investigated; however, the clinical features and treatment outcomes were not reported. Objective: To analyze the clinical features and genotypes of patients with HbH who reside in Taiwan. Methods: We conducted a retrospective analysis of the clinical and molecular characteristics of 38 patients with HbH disease who were undergoing treatment at Kaohsiung Medical University Hospital, Taiwan. Results: Initial Hb levels were lower and the numbers of patients requiring iron-chelation therapy were higher in the nondeletional HbH group than in the deletional HbH group (P
CITATION STYLE
Lin, P. C., Chang, T. T., Liao, Y. M., Tsai, S. P., Chen, Y. C., Hsu, W. Y., … Chiou, S. S. (2019). Clinical features and genotypes of patients with hemoglobin H disease in Taiwan. Lab Medicine, 50(2), 168–173. https://doi.org/10.1093/labmed/lmy043
Mendeley helps you to discover research relevant for your work.